Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 594

1.

Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, Allen LF, Hassanein T.

Gastroenterology. 2018 May 17. pii: S0016-5085(18)34545-1. doi: 10.1053/j.gastro.2018.05.025. [Epub ahead of print]

PMID:
29778606
2.

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.

Agarwal K, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, Ahn SH, Izumi N, Chuang WL, Bae H, Sharma M, Janssen HLA, Pan CQ, Çelen MK, Furusyo N, Shalimar D, Yoon KT, Trinh H, Flaherty JF, Gaggar A, Lau AH, Cathcart AL, Lin L, Bhardwaj N, Suri V, Mani Subramanian G, Gane EJ, Buti M, Chan HLY; GS-US-320-0110; GS-US-320-0108 Investigators.

J Hepatol. 2018 Apr;68(4):672-681. doi: 10.1016/j.jhep.2017.11.039. Epub 2018 Jan 17.

PMID:
29756595
3.

Pulmonary Resection for Lung Cancer Following Transcatheter Aortic Valve Implantation for Severe Aortic Valve Stenosis: A Case Report.

Komatsu H, Izumi N, Tsukioka T, Chung K, Toda M, Hara K, Nishiyama N.

Ann Thorac Cardiovasc Surg. 2018 Apr 26. doi: 10.5761/atcs.cr.18-00028. [Epub ahead of print]

4.

Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method.

Tamaki N, Koizumi Y, Hirooka M, Yada N, Takada H, Nakashima O, Kudo M, Hiasa Y, Izumi N.

Hepatol Res. 2018 Apr 21. doi: 10.1111/hepr.13179. [Epub ahead of print]

PMID:
29679473
5.

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.

Mashiba T, Joko K, Kurosaki M, Ochi H, Osaki Y, Kojima Y, Nakata R, Goto T, Takehiro A, Kimura H, Mitsuda A, Kawanami C, Uchida Y, Ogawa C, Kusakabe A, Narita R, Ide Y, Abe T, Tsuji K, Kitamura T, Okada K, Sohda T, Shigeno M, Satou T, Izumi N.

PLoS One. 2018 Apr 16;13(4):e0194704. doi: 10.1371/journal.pone.0194704. eCollection 2018.

6.

Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.

Kudo M, Ueshima K, Yokosuka O, Ogasawara S, Obi S, Izumi N, Aikata H, Nagano H, Hatano E, Sasaki Y, Hino K, Kumada T, Yamamoto K, Imai Y, Iwadou S, Ogawa C, Okusaka T, Kanai F, Akazawa K, Yoshimura KI, Johnson P, Arai Y; SILIUS study group.

Lancet Gastroenterol Hepatol. 2018 Jun;3(6):424-432. doi: 10.1016/S2468-1253(18)30078-5. Epub 2018 Apr 7.

PMID:
29631810
7.

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.

Tsuji K, Kurosaki M, Itakura J, Mori N, Takaki S, Hasebe C, Akahane T, Joko K, Yagisawa H, Takezawa J, Nakata R, Kusakabe A, Kojima Y, Kimura H, Tamada T, Kobashi H, Mitsuda A, Kondou M, Ogawa C, Uchida Y, Sohda T, Narita R, Izumi N.

J Gastroenterol. 2018 Apr 6. doi: 10.1007/s00535-018-1455-1. [Epub ahead of print]

PMID:
29626296
8.

Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.

Kaibori M, Yoshii K, Hasegawa K, Ogawa A, Kubo S, Tateishi R, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan.

Ann Surg. 2018 Mar 30. doi: 10.1097/SLA.0000000000002751. [Epub ahead of print]

PMID:
29608544
9.

Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.

Fujii H, Kimura H, Kurosaki M, Hasebe C, Akahane T, Yagisawa H, Kato K, Yoshida H, Itakura J, Sakita S, Satou T, Okada K, Kusakabe A, Kojima Y, Kondo M, Morita A, Nasu A, Tamada T, Okushin H, Kobashi H, Tsuji K, Joko K, Ogawa C, Uchida Y, Mitsuda A, Sohda T, Ide Y, Izumi N.

Hepatol Res. 2018 Feb 26. doi: 10.1111/hepr.13070. [Epub ahead of print]

PMID:
29480939
10.

Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer.

Tsukioka T, Izumi N, Kyukwang C, Komatsu H, Toda M, Hara K, Nishiyama N.

Ann Thorac Cardiovasc Surg. 2018 Feb 16. doi: 10.5761/atcs.oa.17-00215. [Epub ahead of print]

11.

PNLDC1, mouse pre-piRNA Trimmer, is required for meiotic and post-meiotic male germ cell development.

Nishimura T, Nagamori I, Nakatani T, Izumi N, Tomari Y, Kuramochi-Miyagawa S, Nakano T.

EMBO Rep. 2018 Mar;19(3). pii: e44957. doi: 10.15252/embr.201744957. Epub 2018 Feb 14.

12.

Transcriptome profiling reveals infection strategy of an insect maculavirus.

Katsuma S, Kawamoto M, Shoji K, Aizawa T, Kiuchi T, Izumi N, Ogawa M, Mashiko T, Kawasaki H, Sugano S, Tomari Y, Suzuki Y, Iwanaga M.

DNA Res. 2018 Jan 17. doi: 10.1093/dnares/dsx056. [Epub ahead of print]

PMID:
29360973
13.

Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization.

Yasui Y, Tsuchiya K, Kurosaki M, Takeguchi T, Takeguchi Y, Okada M, Wang W, Kubota Y, Goto T, Komiyama Y, Higuchi M, Takaura K, Hayashi T, Takada H, Tamaki N, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Enomoto N, Himeno Y, Izumi N.

Hepatol Res. 2018 May;48(6):442-450. doi: 10.1111/hepr.13048. Epub 2018 Feb 9.

PMID:
29278654
14.

Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.

Takayasu K, Arii S, Sakamoto M, Matsuyama Y, Kudo M, Kaneko S, Nakashima O, Kadoya M, Izumi N, Takayama T, Ku Y, Kumada T, Kubo S, Kokudo T, Hagiwara Y, Kokudo N; Liver Cancer Study Group of Japan.

Liver Int. 2018 Mar;38(3):484-493. doi: 10.1111/liv.13670. Epub 2018 Jan 25.

PMID:
29266722
15.

Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report.

Komatsu H, Izumi N, Tsukioka T, Toda M, Hara K, Miyamoto H, Nishiyama N.

Ann Thorac Cardiovasc Surg. 2017 Dec 15. doi: 10.5761/atcs.cr.17-00092. [Epub ahead of print]

16.

Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.

Hiraoka A, Michitaka K, Kumada T, Izumi N, Kadoya M, Kokudo N, Kubo S, Matsuyama Y, Nakashima O, Sakamoto M, Takayama T, Kokudo T, Kashiwabara K, Kudo M.

Liver Cancer. 2017 Nov;6(4):325-336. doi: 10.1159/000479984. Epub 2017 Sep 22.

17.

Structural basis for arginine methylation-independent recognition of PIWIL1 by TDRD2.

Zhang H, Liu K, Izumi N, Huang H, Ding D, Ni Z, Sidhu SS, Chen C, Tomari Y, Min J.

Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12483-12488. doi: 10.1073/pnas.1711486114. Epub 2017 Nov 8.

18.

Platelet-to-lymphocyte ratio predicts the prognosis of patients with non-small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy.

Toda M, Tsukioka T, Izumi N, Komatsu H, Okada S, Hara K, Miyamoto H, Ito R, Shibata T, Nishiyama N.

Thorac Cancer. 2018 Jan;9(1):112-119. doi: 10.1111/1759-7714.12547. Epub 2017 Nov 3.

19.

Simplified model of pinhole imaging for quantifying systematic errors in image shape.

Benedetti LR, Izumi N, Khan SF, Kyrala GA, Landen OL, Ma T, Nagel SR, Pak A.

Appl Opt. 2017 Nov 1;56(31):8719-8731. doi: 10.1364/AO.56.008719.

PMID:
29091687
20.

Diagnosis of Fibrosis and Activity by a Combined Use of Strain and Shear Wave Imaging in Patients with Liver Disease.

Yada N, Tamaki N, Koizumi Y, Hirooka M, Nakashima O, Hiasa Y, Izumi N, Kudo M.

Dig Dis. 2017;35(6):515-520. doi: 10.1159/000480140. Epub 2017 Oct 17.

PMID:
29040983
21.

Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.

Kudo M, Cheng AL, Park JW, Park JH, Liang PC, Hidaka H, Izumi N, Heo J, Lee YJ, Sheen IS, Chiu CF, Arioka H, Morita S, Arai Y.

Lancet Gastroenterol Hepatol. 2018 Jan;3(1):37-46. doi: 10.1016/S2468-1253(17)30290-X. Epub 2017 Oct 4.

PMID:
28988687
22.

Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey.

Kaibori M, Yoshii K, Yokota I, Hasegawa K, Nagashima F, Kubo S, Kon M, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan.

Ann Surg. 2017 Sep 15. doi: 10.1097/SLA.0000000000002526. [Epub ahead of print]

PMID:
28922205
23.

Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer.

Tsukioka T, Izumi N, Mizuguchi S, Kyukwang C, Komatsu H, Toda M, Hara K, Miyamoto H, Nishiyama N.

Int J Clin Oncol. 2018 Feb;23(1):66-72. doi: 10.1007/s10147-017-1185-z. Epub 2017 Sep 1.

PMID:
28864833
24.

Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients with non-valvular atrial fibrillation: a propensity matched analysis of administrative claims data.

Kohsaka S, Murata T, Izumi N, Katada J, Wang F, Terayama Y.

Curr Med Res Opin. 2017 Nov;33(11):1955-1963. doi: 10.1080/03007995.2017.1374935. Epub 2017 Sep 12.

PMID:
28857611
25.

Solitary splenic metastasis from lung adenocarcinoma: A case report.

Hara K, Izumi N, Tsukioka T, Komatsu H, Toda M, Miyamoto H, Suzuki S, Kimura T, Shibata T, Nishiyama N.

Thorac Cancer. 2017 Sep;8(5):539-542. doi: 10.1111/1759-7714.12477. Epub 2017 Jul 21.

26.

Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double-blind, controlled trial.

Hidaka H, Kokubu S, Sato T, Katsushima S, Izumi N, Igura T, Asahara S, Notsumata K, Osaki Y, Tsuji K, Kawanaka H, Akahoshi T, Hirota S, Matsutani S; NPB-06 study group.

Hepatol Res. 2018 Feb;48(3):E107-E116. doi: 10.1111/hepr.12934. Epub 2017 Aug 7.

PMID:
28666312
27.

Response criteria of tolvaptan for the treatment of hepatic edema.

Hiramine Y, Uojima H, Nakanishi H, Hiramatsu A, Iwamoto T, Kimura M, Kawaratani H, Terai S, Yoshiji H, Uto H, Sakaida I, Izumi N, Okita K, Koike K.

J Gastroenterol. 2018 Feb;53(2):258-268. doi: 10.1007/s00535-017-1366-6. Epub 2017 Jun 29.

PMID:
28664229
28.

Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey.

Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, Kudo M, Kubo S, Sakamoto M, Nakashima O, Kumada T, Kokudo N; Liver Cancer Study Group of Japan.

Hepatology. 2017 Aug;66(2):510-517. doi: 10.1002/hep.29225. Epub 2017 Jun 26.

PMID:
28437844
29.

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

Buti M, Gane E, Seto WK, Chan HL, Chuang WL, Stepanova T, Hui AJ, Lim YS, Mehta R, Janssen HL, Acharya SK, Flaherty JF, Massetto B, Cathcart AL, Kim K, Gaggar A, Subramanian GM, McHutchison JG, Pan CQ, Brunetto M, Izumi N, Marcellin P; GS-US-320-0108 Investigators.

Lancet Gastroenterol Hepatol. 2016 Nov;1(3):196-206. doi: 10.1016/S2468-1253(16)30107-8. Epub 2016 Sep 22. Erratum in: Lancet Gastroenterol Hepatol. 2016 Nov;1(3):e2.

PMID:
28404092
30.

Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.

Komiyama Y, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Yasui Y, Tamaki N, Takada H, Higuchi M, Gotou T, Kubota Y, Takaura K, Hayashi T, Oh W, Okada M, Enomoto N, Izumi N.

PLoS One. 2017 Mar 31;12(3):e0174649. doi: 10.1371/journal.pone.0174649. eCollection 2017.

31.

Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma.

Tamaki N, Kuno A, Matsuda A, Tsujikawa H, Yamazaki K, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Korenaga M, Mizokami M, Kurosaki M, Sakamoto M, Narimatsu H, Izumi N.

Sci Rep. 2017 Mar 21;7(1):244. doi: 10.1038/s41598-017-00357-8.

32.

Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP.

Kashihara Y, Ieiri I, Yoshikado T, Maeda K, Fukae M, Kimura M, Hirota T, Matsuki S, Irie S, Izumi N, Kusuhara H, Sugiyama Y.

J Pharm Sci. 2017 Sep;106(9):2688-2694. doi: 10.1016/j.xphs.2017.03.010. Epub 2017 Mar 18.

PMID:
28322941
33.

Mutual interaction between endothelial cells and mural cells enhances BMP9 signaling in endothelial cells.

Tachida Y, Izumi N, Sakurai T, Kobayashi H.

Biol Open. 2017 Mar 15;6(3):370-380. doi: 10.1242/bio.020503.

34.

Publisher's Note: Development of improved radiation drive environment for high foot implosions at the National Ignition Facility [Phys. Rev. Lett. 117, 225002 (2016)].

Hinkel DE, Berzak Hopkins LF, Ma T, Ralph JE, Albert F, Benedetti LR, Celliers PM, Do Ppner T, Goyon CS, Izumi N, Jarrott LC, Khan SF, Kline JL, Kritcher AL, Kyrala GA, Nagel SR, Pak AE, Patel P, Rosen MD, Rygg JR, Schneider MB, Turnbull DP, Yeamans CB, Callahan DA, Hurricane OA.

Phys Rev Lett. 2017 Feb 24;118(8):089902. doi: 10.1103/PhysRevLett.118.089902. Epub 2017 Feb 22.

PMID:
28282185
35.

Identifying a size-specific hazard of silica nanoparticles after intravenous administration and its relationship to the other hazards that have negative correlations with the particle size in mice.

Handa T, Hirai T, Izumi N, Eto SI, Tsunoda SI, Nagano K, Higashisaka K, Yoshioka Y, Tsutsumi Y.

Nanotechnology. 2017 Mar 1;28(13):135101. doi: 10.1088/1361-6528/aa5d7c. Epub 2017 Feb 27.

PMID:
28240988
36.

Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey.

Toyoda H, Tada T, Johnson PJ, Izumi N, Kadoya M, Kaneko S, Kokudo N, Ku Y, Kubo S, Kumada T, Matsuyama Y, Nakashima O, Sakamoto M, Takayama T, Kudo M; Liver Cancer Study Group of Japan.

J Gastroenterol. 2017 Oct;52(10):1112-1121. doi: 10.1007/s00535-017-1321-6. Epub 2017 Feb 21.

PMID:
28224228
37.

Hepatitis B surface antigen reduction by switching from long-term nucleoside/nucleotide analogue administration to pegylated interferon.

Tamaki N, Kurosaki M, Kusakabe A, Orito E, Joko K, Kojima Y, Kimura H, Uchida Y, Hasebe C, Asahina Y, Izumi N; Japanese Red Cross Hospital Liver Study Group.

J Viral Hepat. 2017 Aug;24(8):672-678. doi: 10.1111/jvh.12691. Epub 2017 Mar 20.

PMID:
28199034
38.

Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.

Matsuura K, Sawai H, Ikeo K, Ogawa S, Iio E, Isogawa M, Shimada N, Komori A, Toyoda H, Kumada T, Namisaki T, Yoshiji H, Sakamoto N, Nakagawa M, Asahina Y, Kurosaki M, Izumi N, Enomoto N, Kusakabe A, Kajiwara E, Itoh Y, Ide T, Tamori A, Matsubara M, Kawada N, Shirabe K, Tomita E, Honda M, Kaneko S, Nishina S, Suetsugu A, Hiasa Y, Watanabe H, Genda T, Sakaida I, Nishiguchi S, Takaguchi K, Tanaka E, Sugihara J, Shimada M, Kondo Y, Kawai Y, Kojima K, Nagasaki M, Tokunaga K, Tanaka Y; Japanese Genome-Wide Association Study Group for Viral Hepatitis.

Gastroenterology. 2017 May;152(6):1383-1394. doi: 10.1053/j.gastro.2017.01.041. Epub 2017 Feb 3.

39.

Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer.

Tsukioka T, Nishiyama N, Izumi N, Mizuguchi S, Komatsu H, Okada S, Toda M, Hara K, Ito R, Shibata T.

Jpn J Clin Oncol. 2017 Apr 1;47(4):363-368. doi: 10.1093/jjco/hyx009.

PMID:
28158497
40.

Huge mediastinal liposarcoma resected by clamshell thoracotomy: a case report.

Toda M, Izumi N, Tsukioka T, Komatsu H, Okada S, Hara K, Ito R, Shibata T, Nishiyama N.

Surg Case Rep. 2017 Dec;3(1):16. doi: 10.1186/s40792-017-0291-5. Epub 2017 Jan 20.

41.

Management of ascites in cirrhotic patients.

Kurosaki M, Nakanishi H, Izumi N.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(1):27-34. doi: 10.11405/nisshoshi.114.27. Review. Japanese. No abstract available.

PMID:
28070092
42.

Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.

Murakawa M, Asahina Y, Kawai-Kitahata F, Nakagawa M, Nitta S, Otani S, Nagata H, Kaneko S, Asano Y, Tsunoda T, Miyoshi M, Itsui Y, Azuma S, Kakinuma S, Tanaka Y, Iijima S, Tsuchiya K, Izumi N, Tohda S, Watanabe M.

J Med Virol. 2017 Jul;89(7):1241-1247. doi: 10.1002/jmv.24763. Epub 2017 Feb 27.

PMID:
28036111
43.

Development of Improved Radiation Drive Environment for High Foot Implosions at the National Ignition Facility.

Hinkel DE, Berzak Hopkins LF, Ma T, Ralph JE, Albert F, Benedetti LR, Celliers PM, Döppner T, Goyon CS, Izumi N, Jarrott LC, Khan SF, Kline JL, Kritcher AL, Kyrala GA, Nagel SR, Pak AE, Patel P, Rosen MD, Rygg JR, Schneider MB, Turnbull DP, Yeamans CB, Callahan DA, Hurricane OA.

Phys Rev Lett. 2016 Nov 25;117(22):225002. Epub 2016 Nov 23. Erratum in: Phys Rev Lett. 2017 Feb 24;118(8):089902.

PMID:
27925754
44.

Hotspot electron temperature from x-ray continuum measurements on the NIF.

Jarrott LC, Benedetti LR, Chen H, Izumi N, Khan SF, Ma T, Nagel SR, Landen OL, Pak A, Patel PK, Schneider M, Scott HA.

Rev Sci Instrum. 2016 Nov;87(11):11E534.

PMID:
27910566
45.

Resolving hot spot microstructure using x-ray penumbral imaging (invited).

Bachmann B, Hilsabeck T, Field J, Masters N, Reed C, Pardini T, Rygg JR, Alexander N, Benedetti LR, Döppner T, Forsman A, Izumi N, LePape S, Ma T, MacPhee AG, Nagel S, Patel P, Spears B, Landen OL.

Rev Sci Instrum. 2016 Nov;87(11):11E201.

PMID:
27910489
46.

Combined neutron and x-ray imaging at the National Ignition Facility (invited).

Danly CR, Christensen K, Fatherley VE, Fittinghoff DN, Grim GP, Hibbard R, Izumi N, Jedlovec D, Merrill FE, Schmidt DW, Simpson RA, Skulina K, Volegov PL, Wilde CH.

Rev Sci Instrum. 2016 Nov;87(11):11D703.

PMID:
27910487
47.

Automated analysis of hot spot X-ray images at the National Ignition Facility.

Khan SF, Izumi N, Glenn S, Tommasini R, Benedetti LR, Ma T, Pak A, Kyrala GA, Springer P, Bradley DK, Town RP.

Rev Sci Instrum. 2016 Nov;87(11):11E334.

PMID:
27910429
48.

Observation of hohlraum-wall motion with spectrally selective x-ray imaging at the National Ignition Facility.

Izumi N, Meezan NB, Divol L, Hall GN, Barrios MA, Jones O, Landen OL, Kroll JJ, Vonhof SA, Nikroo A, Jaquez J, Bailey CG, Hardy CM, Ehrlich RB, Town RP, Bradley DK, Hinkel DE, Moody JD.

Rev Sci Instrum. 2016 Nov;87(11):11E321.

PMID:
27910418
49.

Comparison of implosion core metrics: A 10 ps dilation X-ray imager vs a 100 ps gated microchannel plate.

Nagel SR, Benedetti LR, Bradley DK, Hilsabeck TJ, Izumi N, Khan S, Kyrala GA, Ma T, Pak A.

Rev Sci Instrum. 2016 Nov;87(11):11E311.

PMID:
27910406
50.

Spatial resolution measurements of the advanced radiographic capability x-ray imaging system at energies relevant to Compton radiography.

Hall GN, Izumi N, Landen OL, Tommasini R, Holder JP, Hargrove D, Bradley DK, Lumbard A, Cruz JG, Piston K, Lee JJ, Romano E, Bell PM, Carpenter AC, Palmer NE, Felker B, Rekow V, Allen FV.

Rev Sci Instrum. 2016 Nov;87(11):11E310.

PMID:
27910309

Supplemental Content

Support Center